All eyes have been trained on the life sciences industry as the world hopes for medical solutions to the Covid-19 pandemic. As pharmaceutical and medical device companies have collaborated at a speed and intensity never seen before, we ask if there are lessons that can be learned for how collaboration can work in more normal times. 

We speak to an industry inside, an life sciences lawyer and a business strategy academic about what coronavirus collaboration can teach the business world.